What's more, Nvidia trades at just 27 times forward earnings, a massive discount to Palantir's forward earnings multiple of 145. This makes buying Nvidia a no-brainer right now. It could easily fit ...

Tempus AI's financials have significantly improved, with positive cash flow expected next quarter. Read why TEM stock is a ...

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...

Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China sales recovering faster than expected.

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

Shares of Illumina Inc. ILMN rose 2.33% to $86.62 Friday, on what proved to be an all-around positive trading session for the stock market ... which the company reached on November 5th.

Illumina, which scored in the top 15% of the Best-in-Class World Index, also ranked as the highest-scoring US company in the Life Illumina stock recovered early losses ... and rising competition in ...

Illumina faces a new challenge as China has prohibited the import of the company’s sequencers ... Meanwhile, Citi analysts foresee continued pressure on the stock, highlighting competition from ...

The Chinese government took its economic sanctions against San Diego-based Illumina a step ... could be due to competition from Chinese gene sequencing companies that offer a “good enough ...